ABSTRACT
INTRODUCTION
Actinomycetes especially streptomyces are the most economically and biotechnologically valuable prokaryotes. They are responsible for the production of about half of the discovered bioactive secondary metabolites [1] , notably antibiotics [1] [2] , antitumor agents [3] , immunosuppressive agents [4] and enzymes [5] [6] .
Although the exploitation of marine actinomycetes as a source for discovery of novel secondary metabolites is at an early stage, numerous novel metabolites have been isolated in the past few years. For example; Abyssomicin C is a novel polycyclic polyketide antibiotic produced by a marine Verrucosispora strain [7] , Diazepinomicin is a unique farnesylated dibenzodiazepinone produced by a Micromonospora strain. It possesses antibacterial, anti-inflammatory and antitumor activity [8] , Salinosporamide A is a novel lactone-γ-lactam isolated from a fermentation broth of a new obligate marine actinomycete, Salinispora tropica. This compound is an orally active proteasome inhibitor [9] .
We have previously reported the isolation of indigenous marine actinomycetes strain called Streptomyces sp A11 producing biological activities [10] . We report here the purification and elucidation of chemical structure active compounds produced by Streptomyces sp A11. The objective of this research was production, purification and structure elucidation of antibiotic produced by marine actinomycetes (Streptomyces sp A11).
EXPERIMENTAL SECTION

Materials
Materials used for research as follows: bacto peptone (Oxoid), yeast extract (Oxoid), malt extract (Oxoid), glucose (Merck), iron(III) citrate hydrate (Merck), ethyl acetate (JT Baker), marine agar (Difco), demineral water, sea water, methanol (JT Baker), methanol for HPLC (Merck), silica gel 60 (Merck, 0.063-0.200 mm). 
Instrumentation
Procedure
Fermentation
The isolate Streptomyces sp A11 was inoculated into a 250 mL flask containing 100 mL of the vegetative medium consisting of (g/L): bacto peptone 5 g/L (Oxoid), yeast extract 3 g/L (Oxoid), malt extract 3 g/L (Oxoid), glucose 3 g/L (Merck), demineral water 250 mL, and sea water 750 mL. pH value of the medium was adjusted at 7.6 before sterilization. The flask was incubated at 30°C for 2 days in incubator shaker. 50 mL of this culture was transferred to 1,000 mL of the fermentative medium [11] . Fermentative medium consisted of bacto peptone 15 g/L (Oxoid), yeast extract 3 g/L (Oxoid), iron(III) citrate hydrate 0.3 g/L (Merck), demineral water 250 mL, and sea water 750 mL. pH value of the medium was adjusted at 7.6 before sterilization. The fermentation was carried out at 30°C for 5 days in incubator shaker [12] . The total of working volume for fermentation process was 5,000 mL.
Extraction and purification
Five thousands milliliter of culture broth was centrifuged at 14,000 x g for 15 min. The dark filtrate (supernatant) was divided from biomass and extracted using 5,000 mL ethyl acetate twice (2 x 5,000 mL). Biomass was dried and weighed and extracted using 500 mL of methanol twice. Ethyl acetate phase was concentrated by evaporation under vacuum to the least volume, after the dehydration using anhydrous Na 2 SO 4. At the same time biomass extract (in methanol) was concentrated by evaporation under vacuum to the least volume. Extract of biomass and supernatant were tested by analytical HPLC.
Dry extract of supernatant and extract of biomass were purified using column chromatography (25 x 500 mm). Stationary phase was used silica gel 60 (Merck, 0.063-0.200 mm). Dry extract was injected on column chromatography then eluted stepwise with chloroformmethanol solvent system as follows: First, the column was eluted with 100% chloroform. This repeated by reducing the chloroform 10% and the methanol was increased 10% until percentage of methanol 100%. Thirty fractions were collected and tested for their biological activities. The active fractions obtained from column chromatography were further purified using preparative HPLC. Each fraction from preparative HPLC was collected and test to biological activity. The active fraction was collected and dried using vacuum evaporation. Active compound was elucidated by ESI-MS, 1 H NMR, 13 C NMR, DEPT 13 C NMR, and FTIR.
Biological activity assay
Biological activity was monitored by the agar diffusion paper-disc (6 mm), which are dripped by extract solution, dried and placed over the agar surface plates freshly inoculated with the Escherichia coli ATCC 25922, Staphylococcus aureus ATCC25923, Bacillus subtilis ATCC 66923, Pseudomonas aeruginosa ATCC27853, Candida albican BIOMCC00122 and Aspergillus niger BIOMCC 00134 as test organisms. Suspensions of test organisms were adjusted to 10 6 cfu/mL. The most potent isolates were noted for each test organism, based on the mean of diameter of inhibition zones.
Analysis HPLC
HPLC analysis was performed using HPLC Waters 2695, analytical column Water Symmetry C18 (4.6 x 250 mm, Part No.WAT054275), photodiode array detector, elution was used methanol-water (0-100% linear gradient for 35 min and then isocratic elution with 100% methanol until 10 min), and flow rate of 1.0 mL/min.
Preparative HPLC
Preparative HPLC was conducted using HPLC Waters 2695, photodiode array detector, and analytical column Millipore Water Puresil 5 C18 (4.6 x 150 mm, Part No.N21017). Volume of injection was 50 uL per injection under condition of pressure average 1,267 psi, flow rate 1 mL/min where mobile phase 0-45% methanol -water for 25 min.
Elucidation of chemical structure
Molecular weight and formula were determined using ESI-MS (LCT Premier-XE waters), molecule structure elucidation of active compound were determined using FTIR (Shimadzu 8300), 1 HNMR, 13 CNMR, and DEPT 13 C NMR (Bruker AV-500 (500 MHz)). Fig. 1  and 2 . Fig. 1 showed many peak was emerge, indicating that many compounds were produced by isolate (Fig. 2) . It is mean that this active compound was produced by extracellular secretion.
RESULT AND DISCUSSION
Fermentation isolate
Pattern of HPLC chromatogram of supernatant and biomass extract were showed on Fig. 1 and Fig. 2 . Inhibition of active compound to 4 test organisms was showed on Fig. 3 .
Further purification of the antibiotic has been carried out by column chromatography. Supernatant extract was injected on column chromatography, and then eluted stepwise with methanol-chloroform solvent system. Thirty fractions were collected and each fraction was tested for their biological activities.
Further purification of active fractions was purified by preparative HPLC. Forty fractions were collected and test to biological activity. Fractions that showed biological activity were combined and dried under vacuum. Dried active compound showed white powder and easy dissolved in methanol:chloroform (1:1). Preparative HPLC chromatogram of purification process was presented at Fig. 4 . Fig.4 showed that many compounds have not been eliminated before purification using preparative HPLC. However, after purification using preparative HPLC, a single active compound can be obtained (Fig.  5) . Result from biologically activity assay showed that fraction 10.1 min of preparative HPLC chromatogram (Fig. 4) showed active fraction. Identification of pure active compound using analysis HPLC showed that this active compound have UV visible maximum absorption at 210 and 274.5 nm in methanol. It is reported that the most of peptide antibiotic exhibit maximum absorbance at 210-230 nm and 270-280 nm 13-15. An absorbance at 220-230 nm is corresponding to characteristic absorption of peptide bonds 13. Analysis HPLC Chromatogram and UV visible spectrum of active compound after purification using Determination of molecular weight, formula and structure elucidation of active compound was determined using ESI-MS, H 1 NMR, 13 C NMR, and FTIR, respectively. ESI-MS spectra were obtained on LCT Premier-XE waters. ESI-MS spectra showed that this active compound has molecular weight of 260.0 g/mol. Data base from LCT Premier-XE Waters Program showed that this molecule had 14 carbon, 16 hydrogen, 2 nitrogen, and 3 oxygen. The most possible of molecular formula was C 14 C NMR were presented on Table 2 .
Structure elucidation of compound was also conducted using DEPT 13 C NMR. DEPT 13 C NMR spectrum of active compound was presented on Fig.  11 .
Two singlet carbons representing a ketone group were evident in the 13 C spectrum at δ 170.795 (s) (C1) and δ 166.935 (s) (C4) (see Table 2 , Fig. 9 ). Further analysis of the Carbons at position 3' and 5' appeared more upfield than C2' and C6'. This was due to the shielding effect of the hydroxyl group at C4' toward its ortho coupled carbon (C3' and C5'). A similar phenomenon occurred on C1' (para coupled with C4') which shifted more upfield than C2' and C6'.
The infra red spectrum in a KBr pellet showed characteristic bands at 3383 cm (p-disubstituted benzene ring). This infra red spectrum was closely with previous published spectra for Cyclo (Tyr-Pro) [16] [17] . Infra Red spectrum of active compound produced by Streptomyces sp A11 was presented at Fig. 12 .
This active compound was included in group cyclodipeptide, namely was cyclo (tyrosyl-prolyl). This active compound have the same profile such as 1 H NMR, 13 C NMR, UVmax absorption, Infra red spectrum, and molecular weight with cyclo(tyrosyl-prolyl) that found previous researcher but different origin [18] [19] . Previously, this compound was produced by Alternaria alternate and can be used as a host-specific phytotoxin for spotted knapweed [18] , and produced by Pseudomonas fluorescens GcM5-1A isolated from the pine wood nematode (PWN), Bursaphelenchus xylophilus [19] . 
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